Every record from PeptideMeter · page 4
Runs dual-wavelength detection as standard and reports named related substances rather than totals only. Measured offset against the reference laboratory is -0.024 pp on 569 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042871 | BPC-157 | GGPeps | GGPE-2512-G2285 | 2026-Q2 | 97.96 | 3.43 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042561 | Mazdutide | ERP | ERP-2603-D7882 | 2026-Q2 | 97.94 | 4.04 | 97.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042457 | NAD+ | SWB | SWB-2602-P5992 | 2026-Q2 | 99.06 | 10.72 | 96.8 | Supplier-supplied | 1 | FAIL |
| AX-2026-041583 | CJC-1295 (no DAC) | QSC | QSC-2601-B7339 | 2026-Q2 | 98.81 | 5.36 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043078 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.51 | 5.11 | 90.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042595 | Tirzepatide | GGPeps | GGPE-2604-H8313 | 2026-Q2 | 99.23 | 2.03 | 89.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041584 | CJC-1295 (no DAC) | QSC | QSC-2601-B7339 | 2026-Q2 | 98.88 | 4.83 | 97.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043291 | IGF-1 LR3 | CPC | CPC-2512-S2394 | 2026-Q2 | 98.18 | 2.74 | 99.7 | Supplier-supplied | 0 | PASS |
| AX-2026-041715 | Exenatide | QSC | QSC-2602-P9435 | 2026-Q2 | 98.94 | 5.18 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042902 | Semax | MKM | MKM-2512-B2992 | 2026-Q2 | 99.35 | 7.26 | 107.2 | Supplier-supplied | 2 | FAIL |
| AX-2026-042816 | TB-500 | GGPeps | GGPE-2605-J2051 | 2026-Q2 | 99.30 | 4.47 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041295 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 99.00 | 6.23 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043345 | TB-500 | CPC | CPC-2605-B2433 | 2026-Q2 | 99.10 | 5.89 | 96.5 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042955 | Semaglutide | KP | KP-2601-K4658 | 2026-Q2 | 98.97 | 4.85 | 96.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043394 | BPC-157 | WXT | WXT-2603-K3648 | 2026-Q2 | 98.13 | 4.67 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043168 | BPC-157 | GL Biochem | GLBI-2602-T8420 | 2026-Q2 | 98.35 | 4.73 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043115 | Mazdutide | SSA | SSA-2605-G6781 | 2026-Q2 | 98.45 | 2.48 | 97.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042883 | BPC-157 | MKM | MKM-2605-X2575 | 2026-Q2 | 98.74 | 2.96 | 95.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042345 | Tirzepatide | HJ | HJ-2511-B3546 | 2026-Q2 | 98.83 | 6.00 | 104.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042303 | GHRP-2 | HJ | HJ-2602-W3148 | 2026-Q2 | 99.12 | 1.24 | 98.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041665 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 99.79 | 3.66 | 90.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042022 | Ipamorelin | TFC | TFC-2603-M6766 | 2026-Q2 | 99.93 | 4.64 | 105.3 | Supplier-supplied | 0 | PASS |
| AX-2026-043517 | MGF | BCH | BCH-2511-D7240 | 2026-Q2 | 98.66 | 5.59 | 102.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043211 | ARA-290 | SGN | SGN-2605-X9661 | 2026-Q2 | 97.96 | 7.11 | 101.7 | Supplier-supplied | 1 | FAIL |
| AX-2026-042983 | Desmopressin | KP | KP-2512-U5139 | 2026-Q2 | 98.39 | 2.64 | 95.6 | Buyer-sourced | 1 | FAIL |
| AX-2026-042962 | Retatrutide | KP | KP-2604-N4308 | 2026-Q2 | 98.67 | 5.36 | 103.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042944 | Gonadorelin | MKM | MKM-2512-N3913 | 2026-Q2 | 99.92 | 5.75 | 91.1 | Supplier-supplied | 0 | PASS |
| AX-2026-042362 | Sermorelin | HJ | HJ-2605-A4196 | 2026-Q2 | 98.93 | 5.80 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041941 | Semax | TFC | TFC-2602-F4591 | 2026-Q2 | 99.25 | 8.99 | — | Laboratory-retained | 0 | PASS |
| AX-2026-042622 | KPV | GGPeps | GGPE-2511-K8830 | 2026-Q2 | 98.62 | 5.19 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042568 | Selank | ERP | ERP-2605-M7608 | 2026-Q2 | 99.75 | 6.13 | 104.2 | Supplier-supplied | 0 | PASS |
| AX-2026-041527 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.93 | 2.96 | 105.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042556 | GHK-Cu | ERP | ERP-2601-F7633 | 2026-Q2 | 98.84 | 4.48 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042327 | Tirzepatide | HJ | HJ-2605-D3120 | 2026-Q2 | 98.11 | 4.37 | 100.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041697 | Semaglutide | QSC | QSC-2604-H9231 | 2026-Q2 | 99.76 | 6.75 | 106.7 | Supplier-supplied | 0 | PASS |
| AX-2026-042789 | Retatrutide | GGPeps | GGPE-2604-X1414 | 2026-Q2 | 97.20 | 5.80 | 99.9 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-043489 | GHRP-2 | WXT | WXT-2605-U5824 | 2026-Q2 | 98.83 | 5.76 | 96.6 | Supplier-supplied | 2 | FAIL |
| AX-2026-041297 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 99.05 | 6.39 | 96.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043234 | Kisspeptin-10 | SGN | SGN-2601-A1088 | 2026-Q2 | 98.39 | 4.36 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-043212 | ARA-290 | SGN | SGN-2605-X9661 | 2026-Q2 | 98.58 | 7.00 | — | Supplier-supplied | 1 | MARGINAL |